Skinny Labels, Big Savings Act

This bill creates a legal safe harbor for generic drug manufacturers, protecting them from patent infringement lawsuits when they market drugs for unpatented uses. It specifically shields companies that submit abbreviated drug applications (like 505(j) applications) and avoid referencing patented conditions of use in their labeling, promotion, or marketing. The key provision ensures that describing a generic drug as therapeutically equivalent to a brand-name product - without referencing the patented use - does not constitute infringement of method-of-use patents. This directly affects generic drug companies and brand-name pharmaceutical firms, clarifying that certain labeling practices (called "skinny labels") are legally permissible under patent law.